Patients with mild to moderate ulcerative colitis that does not respond to treatment with 5-ASA derivatives within 2 weeks should receive oral steroids. The recommended daily dose is 40 mg of oral prednisone.
Pacientes con colitis ulcerativa con actividad leve a moderada que no respondan a tratamiento con derivados 5-ASA en 2 semanas, deben recibir manejo con esteroides orales.